Work

BCR-ABL1 tyrosine kinase inhibitor K0706 exhibits preclinical activity in Philadelphia chromosome-positive leukemia

Year: 2019

Type: article

Source: Experimental Hematology

DOI: 10.1016/j.exphem.2019.08.007

Authors: Orlando Antelope, Nadeem A. Vellore, Anthony D. Pomicter, Ami B. Patel, Alexandria Van Scoyk, Phillip M. Clair, Michael W. Deininger, Thomas O'Hare

Institutions: Huntsman Cancer Institute, University of Utah

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Pfizer, National Institutes of Health, National Cancer Institute

Awards: G368171078, G9000041161

OpenAlex ID: W2971990973

FWCI: 1.509

Cites: 11

Cited by: 29

Related to: 10